I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| macrophage | 14 studies | 29% ± 7% | |
| classical monocyte | 12 studies | 23% ± 6% | |
| non-classical monocyte | 10 studies | 23% ± 6% | |
| endothelial cell | 8 studies | 21% ± 6% | |
| conventional dendritic cell | 6 studies | 30% ± 12% | |
| natural killer cell | 6 studies | 17% ± 2% | |
| fibroblast | 6 studies | 23% ± 5% | |
| plasmacytoid dendritic cell | 6 studies | 23% ± 4% | |
| CD16-positive, CD56-dim natural killer cell, human | 5 studies | 18% ± 1% | |
| myeloid cell | 5 studies | 23% ± 5% | |
| epithelial cell | 5 studies | 36% ± 13% | |
| astrocyte | 5 studies | 24% ± 6% | |
| abnormal cell | 5 studies | 28% ± 12% | |
| oligodendrocyte | 5 studies | 27% ± 9% | |
| dendritic cell | 5 studies | 27% ± 9% | |
| basal cell | 4 studies | 25% ± 6% | |
| monocyte | 4 studies | 18% ± 1% | |
| ciliated cell | 4 studies | 21% ± 3% | |
| gamma-delta T cell | 4 studies | 18% ± 1% | |
| secretory cell | 3 studies | 23% ± 4% | |
| B cell | 3 studies | 17% ± 2% | |
| intermediate monocyte | 3 studies | 27% ± 4% | |
| regulatory T cell | 3 studies | 17% ± 0% | |
| GABAergic neuron | 3 studies | 37% ± 13% | |
| glutamatergic neuron | 3 studies | 45% ± 18% | |
| oligodendrocyte precursor cell | 3 studies | 25% ± 7% | |
| CD16-negative, CD56-bright natural killer cell, human | 3 studies | 16% ± 1% | |
| double negative thymocyte | 3 studies | 16% ± 1% |
